Sreekanth K. Chaguturu - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Sreekanth K. Chaguturu
Stock symbol
CVS
Transactions as of
Apr 1, 2023
Transactions value $
$2,895,935
Form type
4
Date filed
4/4/2023, 04:24 PM
Previous filing
Mar 1, 2023
Next filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$138K -1.85K -22.39% $74.31 6.43K Apr 1, 2023 Direct F1
holding CVS Common Stock (Restricted) 22K Apr 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $3.03M +40.8K $74.31 40.8K Apr 1, 2023 Common Stock 40.8K $74.31 Direct F6
holding CVS Stock Option 5.95K Apr 1, 2023 Common Stock 5.95K $75.27 Direct F2
holding CVS Stock Option 9.58K Apr 1, 2023 Common Stock 9.58K $58.34 Direct F3
holding CVS Stock Option 9.5K Apr 1, 2023 Common Stock 9.5K $74.30 Direct F4
holding CVS Stock Option 13K Apr 1, 2023 Common Stock 13K $101.09 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2 Option became exercisable in four equal annual installments, commencing 11/29/2020.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2023.
F6 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.